MediPharm Labs Corp.
MEDIF
$0.06
$0.004.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.80K | -623.50K | -1.41M | -1.56M | -2.72M |
| Total Depreciation and Amortization | 270.40K | 274.70K | 284.10K | 304.90K | 302.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.40K | 184.10K | 198.70K | 140.90K | 224.10K |
| Change in Net Operating Assets | -837.20K | -427.90K | 1.24M | 994.70K | 196.60K |
| Cash from Operations | -305.60K | -592.50K | 312.00K | -114.70K | -2.00M |
| Capital Expenditure | -32.40K | -700.00 | 0.00 | -11.60K | -30.40K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 344.90K | 3.07M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -32.40K | -700.00 | 0.00 | 333.30K | 3.04M |
| Total Debt Issued | 457.00K | -- | 0.00 | 0.00 | 500.00K |
| Total Debt Repaid | -54.00K | -184.00K | -223.00K | -120.00K | -84.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.00K | 46.00K | 40.00K | 47.00K | 31.00K |
| Cash from Financing | 310.50K | -99.20K | -131.30K | -53.00K | 323.10K |
| Foreign Exchange rate Adjustments | 16.20K | 16.50K | -21.50K | -4.40K | 27.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.30K | -675.90K | 159.20K | 161.20K | 1.39M |